So, doesn’t this mean the lack of previous RCT trials and the difficulty of recruiting means we are effectively running out of time because of the high cash burn rate?
Or is the German trial and adoption by BGA the key for short term cash?
Or is the deal with a strategic partner the key here?
- Forums
- ASX - By Stock
- Pancreatic Cancer in the Media
So, doesn’t this mean the lack of previous RCT trials and the...
-
- There are more pages in this discussion • 49 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OSL (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.3¢ |
Change
0.001(4.00%) |
Mkt cap ! $45.40M |
Open | High | Low | Value | Volume |
1.3¢ | 1.3¢ | 1.2¢ | $131.7K | 10.13M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
11 | 5399661 | 1.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.3¢ | 392320 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
11 | 5399661 | 0.012 |
13 | 9742212 | 0.011 |
29 | 24421132 | 0.010 |
12 | 4961222 | 0.009 |
6 | 4666250 | 0.008 |
Price($) | Vol. | No. |
---|---|---|
0.013 | 392320 | 7 |
0.014 | 6631281 | 10 |
0.015 | 8744100 | 6 |
0.016 | 4428334 | 4 |
0.017 | 5088882 | 2 |
Last trade - 13.57pm 13/09/2024 (20 minute delay) ? |
Featured News
OSL (ASX) Chart |